Dula Man, Ph.D.

Junior Research Scientist

Dula’s research goal is to correct sickle cell disease-associated hemoglobin beta gene (HBB) point mutation. He is employing the CRISPR/Cas9 system and other advanced techniques to edit the HBB gene in CD34+ cells. Dula is the principal investigator on one of three target projects funded by the NIH COBRE, Delaware Comprehensive Sickle Cell Research Center. He has a Ph.D. in molecular biology from University of Texas at El Paso, and has completed postdoctoral training at the University of California Irvine. His research expertise includes molecular biology, DNA repair, biochemistry and nanofiber engineering.